WHOOP CEO Says Its Blood Pressure Tool 'Follows the Law'

Key Concepts

• Blood Pressure Insights: A feature providing daily blood pressure estimates via a wrist-worn wearable, calibrated with a cuff, and offering insights into its impact on wellness factors.
• 21st Century Cures Act: Legislation that distinguishes between wellness-intended features and medical devices, stipulating that the former should not be regulated by the FDA.
• Intended Use: The primary determinant of whether a product falls under FDA regulation; wellness vs. medical diagnosis.
• Wellness vs. Medical Applications: Differentiation between using physiological metrics for general well-being (e.g., exercise, stress, sleep monitoring) versus diagnosing medical conditions (e.g., AFib).
• WOOP 5 vs. WOOP Medical Grade (PMG): Two hardware versions, with the PMG having a medically cleared EKG feature for AFib detection, distinguishing it from the standard WOOP 5.

FDA Authority and the 21st Century Cures Act

The core issue revolves around the FDA's claim of authority over WOOP's Blood Pressure Insights feature. WOOP argues that the 21st Century Cures Act explicitly states that wellness-intended features are not subject to FDA regulation. The company emphasizes that the feature is designed to provide users with insights into how their blood pressure affects various aspects of their wellness, such as sleep, stress, and nutrition, rather than diagnosing medical conditions.

Intended Use and the Wellness vs. Medical Distinction

The key argument centers on the "intended use" of the Blood Pressure Insights feature. WOOP contends that its primary purpose is wellness-oriented, similar to heart rate monitoring for exercise or sleep tracking. The company acknowledges that blood pressure monitoring can have medical applications, but maintains that its feature is designed for general wellness insights. They are also exploring FDA-cleared products for medical diagnosis in the long term.

Examples and Use Cases

• Heart Rate Monitoring: Used as an example to illustrate the distinction between wellness (exercise tracking) and medical (AFib diagnosis) applications.
• Blood Pressure Insights: Provides daily estimates and insights into how blood pressure affects wellness factors like sleep and stress.

WOOP 5 vs. WOOP Medical Grade (PMG)

The distinction between WOOP 5 and WOOP PMG is crucial. The WOOP PMG has a medically cleared EKG feature for detecting AFib, which required two and a half years of collaboration with the FDA. Both devices offer wellness features, but the EKG functionality differentiates the PMG as a medical device. The WOOP app includes medical disclaimers to clarify the intended use of each feature.

WOOP's Response and Future Actions

WOOP disagrees with the FDA's assessment and has responded to the warning letter, outlining its legal position and the wellness-oriented nature of the Blood Pressure Insights feature. The company intends to continue engaging with the FDA to resolve the issue.

Impact on Innovation and Market Reception

The speaker emphasizes that WOOP is one of the first wearables capable of accurately measuring blood pressure from the wrist, a significant innovation. The company is concerned that the FDA's stance could stifle innovation and limit Americans' access to health data. The Blood Pressure Insights feature has been well-received by users, who report that it is accurate and helps them understand their wellness. The technology is also accepted in 50 other markets around the world.

Notable Quotes

• "The 21st Century Cures Act makes it very clear if a product is intended for a wellness use case, it's not supposed to be regulated by the FDA."
• "We think in this specific case they [the FDA] have it wrong and so we're going to continue engaging with them on it."
• "Fighting for innovation, fighting for Americans access to health data is the right thing to do."

Technical Terms and Concepts

• Blood Pressure Insights: WOOP's feature providing daily blood pressure estimates and wellness insights.
• 21st Century Cures Act: Legislation defining the FDA's regulatory scope.
• Intended Use: The primary purpose of a product, determining FDA oversight.
• AFib: Atrial fibrillation, a heart condition detectable by the WOOP PMG's EKG feature.
• EKG: Electrocardiogram, a test that records the electrical activity of the heart.

Synthesis/Conclusion

WOOP is challenging the FDA's claim of authority over its Blood Pressure Insights feature, arguing that it is a wellness-intended application exempt from FDA regulation under the 21st Century Cures Act. The company differentiates its product from medical devices by emphasizing its focus on providing users with insights into how blood pressure affects their overall wellness. WOOP is committed to engaging with the FDA to resolve the issue and advocating for policies that support innovation and access to health data. The core of the dispute lies in the interpretation of "intended use" and the distinction between wellness and medical applications of blood pressure monitoring.